Department of Cornea and Refractive Surgery, Sankara Eye Hospital, Coimbatore, Tamil Nadu, India.
Indian J Ophthalmol. 2020 Jan;68(1):224-226. doi: 10.4103/ijo.IJO_475_19.
Corneal collagen cross-linking (CXL) is an effective treatment for arresting progression in keratoconus cases. It is considered safe despite a few complications that have been recorded earlier. In this case series, we report a rare and late complication caused due to severe stromal thinning up to Descemet's membrane in three patients who underwent CXL 3 to 6 years back for keratoconus. Deep anterior lamellar keratoplasty (DALK) was then done for the affected eye with good outcomes. This case series highlights the possible late effects of UVA irradiation post CXL.
角膜胶原交联 (CXL) 是一种有效的治疗方法,可阻止圆锥角膜的进展。尽管之前已经记录了一些并发症,但它被认为是安全的。在本病例系列中,我们报告了三例患者在接受 CXL 治疗 3 至 6 年后因严重的基质变薄至后弹力层而引起的罕见且迟发的并发症,这些患者因圆锥角膜而接受了 CXL 治疗。然后对受影响的眼睛进行了深层前板层角膜移植术 (DALK),结果良好。本病例系列强调了 CXL 后 UVA 照射可能产生的迟发效应。